All regulations
Nonrulemaking
FDA
FDA-2022-N-2390
Proposal To Refuse To Approve a New Drug Application Supplement for Hetlioz (Tasimelteon); Opportunity for a Hearing
Documents
576
Comments
0
Key Dates
Comment Period OpensOct 11, 2022
Comment Period ClosesAug 7, 2024
Documents
Keywords
Proposal To Refuse To Approve a New Drug
Application Supplement for Hetlioz
(Tasimelteon); Opportunity for a Hearing
Notice
CDER
2022-536
Open
Data from Regulations.gov